CareDx, Inc. (CDNA): Price and Financial Metrics


CareDx, Inc. (CDNA)

Today's Latest Price: $51.33 USD

0.01 (0.02%)

Updated Oct 20 4:00pm

Add CDNA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

CDNA Stock Summary

  • Price to trailing twelve month operating cash flow for CDNA is currently 122.19, higher than 97.05% of US stocks with positive operating cash flow.
  • With a price/sales ratio of 16.77, CareDx Inc has a higher such ratio than 90.92% of stocks in our set.
  • As for revenue growth, note that CDNA's revenue has grown 46.69% over the past 12 months; that beats the revenue growth of 89.39% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to CareDx Inc are EPAY, PSTG, GKOS, LPSN, and SVMK.
  • CDNA's SEC filings can be seen here. And to visit CareDx Inc's official web site, go to www.caredx.com.

CDNA Stock Price Chart Interactive Chart >

Price chart for CDNA

CDNA Price/Volume Stats

Current price $51.33 52-week high $54.85
Prev. close $51.32 52-week low $13.04
Day low $50.57 Volume 304,300
Day high $52.96 Avg. volume 677,797
50-day MA $37.73 Dividend yield N/A
200-day MA $29.80 Market Cap 2.51B

CareDx, Inc. (CDNA) Company Bio


CareDx, Inc. focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is based in Brisbane, California.


CDNA Latest News Stream


Event/Time News Detail
Loading, please wait...

CDNA Latest Social Stream


Loading social stream, please wait...

View Full CDNA Social Stream

Latest CDNA News From Around the Web

Below are the latest news stories about CareDx Inc that investors may wish to consider to help them evaluate CDNA as an investment opportunity.

The Daily Biotech Pulse: Amag Spikes On Takeover Rumors, Zosano Wilts On Regulatory Setback, Pulmonx Makes Wall Street Debut

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 30) Acceleron Pharma Inc (NASDAQ: XLRN ) Annexon Inc (NASDAQ: ANNX ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) CTI BioPharma Corp (NASDAQ: CTIC ) I-Mab ADR (NASDAQ: IMAB ) Insulet Corporation (NASDAQ: PODD ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kura Oncology Inc (NASDAQ: KURA ) LifeSci Acquisition Corp (NASDAQ: LSAC ) (the blank check company announced a business combination with oncology-focused Vincera Pharma) Mirati Th...

Benzinga | October 1, 2020

Transplant Diagnostics Market With Current Trends Analysis 2020: Omixon Ltd., CareDx, Affymetrix, Inc, Abbott Laboratories, Inc, Thermo Fisher Scientific, Inc

The Business Research Company offers " Transplant Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective

OpenPR | September 29, 2020

CareDx EPS beats by $0.08, beats on revenue

CareDx (CDNA): Q2 Non-GAAP EPS of $0.04 beats by $0.08; GAAP EPS of -$0.15 in-line.Revenue of $41.8M (+32.9% Y/Y) beats by $6.19M.Press Release...

Seeking Alpha | August 4, 2020

CareDx to Participate at the Canaccord Genuity 40th Annual Growth Conference

SOUTH SAN FRANCISCO, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announces today it will be participating in the Canaccord Genuity 40th Annual Growth Conference, scheduled to be held virtually August 11-13, 2020. CareDx’s management is scheduled to present on Wednesday, August 12, 2020, at 1:00 p.m. EDT. Interested parties may access a live audio webcast of the presentation by visiting the “Investors” section of the company’s website at investors.caredxinc.com. About CareDx CareDx, Inc., headquartered in South San Francisco, California, is a leading precision me...

Yahoo | July 30, 2020

3 Artificial Intelligence Stocks With Long-Term Narratives

Artificial intelligence (AI) is a buzzword in tech these days. The term, which encompasses a range of technologies including machine learning and data analysis. The goal is to create systems that can perceive, learn, and reason in ways that mimic human capabilities. At its best, AI will allow machines to understand the gestalt of a situation and react accordingly, a capability that humans take for granted – but has tended to elude computer systems, which in their turn excel at analyzing minute details.A wide range of tech companies are working on AI systems; artificial intelligence holds the promise of real-time data analysis and situation monitoring, with the machines capable of handling routine decisions. While it hasn’t been achieved yet, the outlines of success are visible on the ho...

Yahoo | July 25, 2020

Read More 'CDNA' Stories Here

CDNA Price Returns

1-mo 53.36%
3-mo 53.22%
6-mo 106.31%
1-year 88.57%
3-year 777.44%
5-year 1,033.11%
YTD 137.97%
2019 -14.20%
2018 242.51%
2017 171.85%
2016 -57.81%
2015 -11.72%

Continue Researching CDNA

Want to see what other sources are saying about CareDx Inc's financials and stock price? Try the links below:

CareDx Inc (CDNA) Stock Price | Nasdaq
CareDx Inc (CDNA) Stock Quote, History and News - Yahoo Finance
CareDx Inc (CDNA) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8879 seconds.